IJAR 2022
DOI: 10.36106/ijar/9301693
|View full text |Cite
|
Sign up to set email alerts
|

The Evolution of Antiviral Agent Molnupiravir for Treatment and Prophylaxis of Covid-19 in Pandemic- Review Article

Abstract: COVID-19 is currently well known among the general population. The current pandemic treatment requires patient compliant, safe, tolerable, and orally effective. RNA dependent RNA polymerase (RdRp) is an important enzyme involved in RNA synthesis by the formation of phosphodiester bonds within the virus. Effective oral antiviral agents are urgently needed to treat, block transmission and prevent progression to severe illness in COVID-19. Molnupiravir is a orally active RdRp inhibitor. The Developmental steps of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 7 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?